Gene · 5961
Papers1,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinguishing ABCA4 from PRPH2-related disease: qualitative analysis of examination and imaging features. | Ophthalmic Genet | 2025 | 39586833 | PubTator, text mining | PubMed |
| PRPH2-ASSOCIATED RETINAL DISEASES: A SYSTEMATIC REVIEW OF PHENOTYPIC FINDINGS. | Am J Ophthalmol | 2025 | 39515456 | PubTator, text mining | PubMed |
| Using Multimodal Imaging to Refine the Phenotype of PRPH2-associated Retinal Degeneration. | Ophthalmol Retina | 2025 | 39089460 | PubTator, text mining | PubMed |
| Signal Peptides and Their Fragments in Post-Translation: Novel Insights of Signal Peptides. | Int J Mol Sci | 2024 | 39769297 | PubTator, text mining | PubMed |
| Phenotypic and Genetic Heterogeneity of a Pakistani Cohort of 15 Consanguineous Families Segregating Variants in Leber Congenital Amaurosis-Associated Genes. | Genes (Basel) | 2024 | 39766915 | PubTator, text mining | PubMed |
| Clinical and Imaging Characteristics of PRPH2 Retinopathies in a Longitudinal Cohort and Diagnostic Implications. | Invest Ophthalmol Vis Sci | 2024 | 39693084 | PubTator, text mining | PubMed |
| Determining Tyre Adhesion Characteristics Based on the Road Tests of Automobiles. | Sensors (Basel) | 2024 | 39685984 | PubTator, text mining | PubMed |
| Epiretinal Membrane: Correlations Among Clinical, Immunohistochemical, and Biochemical Features and Their Prognostic Implications. | Invest Ophthalmol Vis Sci | 2024 | 39661356 | PubTator, text mining | PubMed |
| Intrafamilial Phenotypic Variability in PRPH2-Related Retinopathy. | Cureus | 2024 | 39610584 | PubTator, text mining | PubMed |
| Phenotypic and Genetic Spectrum in 309 Consecutive Pediatric Patients with Inherited Retinal Disease. | Int J Mol Sci | 2024 | 39596324 | PubTator, text mining | PubMed |
| Editorial Comment. | Indian J Urol | 2024 | 39555425 | PubTator, text mining | PubMed |
| Image tampering detection based on RDS-YOLOv5 feature enhancement transformation. | Sci Rep | 2024 | 39477969 | PubTator, text mining | PubMed |
| 18-Years of single-centre DNA testing in over 7000 index cases with inherited retinal dystrophies and optic neuropathies. | Sci Rep | 2024 | 39462066 | PubTator, text mining | PubMed |
| Current and Future Directions in Developing Effective Treatments for PRPH2-Associated Retinal Diseases: A Workshop Report. | Transl Vis Sci Technol | 2024 | 39382871 | PubTator, text mining | PubMed |
| Guide assignment in single-cell CRISPR screens using crispat. | Bioinformatics | 2024 | 39240651 | PubTator, text mining | PubMed |
| Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. | Nat Commun | 2024 | 39030161 | PubTator, text mining | PubMed |
| NR2E3 inhibits the inflammation and apoptosis in diabetic retinopathy by regulating the AHR/IL-17A signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38884674 | PubTator, text mining | PubMed |
| Pigmentary retinal dystrophy associated with peroxisome biogenesis disorder-Zellweger syndrome spectrum. | Oxf Med Case Reports | 2024 | 38860019 | PubTator, text mining | PubMed |
| Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. | Nat Commun | 2024 | 38834544 | PubTator, text mining | PubMed |
| Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients. | Invest Ophthalmol Vis Sci | 2024 | 38743414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5961/papers?page=7